1. Home
  2. STAG vs LEGN Comparison

STAG vs LEGN Comparison

Compare STAG & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stag Industrial Inc.

STAG

Stag Industrial Inc.

HOLD

Current Price

$38.00

Market Cap

7.3B

Sector

Real Estate

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$36.28

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAG
LEGN
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
5.9B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
STAG
LEGN
Price
$38.00
$36.28
Analyst Decision
Hold
Strong Buy
Analyst Count
9
12
Target Price
$39.67
$61.33
AVG Volume (30 Days)
1.0M
2.7M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
4.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$845,184,000.00
N/A
Revenue This Year
$8.59
$42.68
Revenue Next Year
$9.28
$30.52
P/E Ratio
N/A
N/A
Revenue Growth
10.14
N/A
52 Week Low
$33.72
$16.24
52 Week High
$39.99
$45.30

Technical Indicators

Market Signals
Indicator
STAG
LEGN
Relative Strength Index (RSI) 53.01 65.00
Support Level $37.55 $31.84
Resistance Level $39.39 $37.50
Average True Range (ATR) 0.65 2.85
MACD 0.07 0.32
Stochastic Oscillator 74.38 86.09

Price Performance

Historical Comparison
STAG
LEGN

About STAG Stag Industrial Inc.

Stag Industrial Inc is a REIT focused on the acquisition, ownership, development, and operation of industrial properties throughout the United States. Its platform is designed to (i) identify properties for acquisition that offer attractive returns across CBRE-EA Tier 1 industrial real estate markets, industries, and tenants, (ii) provide growth through the ownership of high-quality assets, property management and pursuit of acquisitions in an attractive opportunity set, and (iii) capitalize its business appropriately given the characteristics of its assets. The majority of its portfolio is single-tenant industrial properties throughout the United States. The company derives the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: